SubHero Banner

Ozobax (baclofen) – New drug approval

September 18, 2019 - The FDA approved Metacel Pharmaceuticals’ Ozobax (baclofen), for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Ozobax may also be of some value in patients with spinal cord injuries and other spinal cord diseases.

Download PDF